5.19
price up icon5.49%   0.27
 
loading
Precedente Chiudi:
$4.92
Aprire:
$4.8
Volume 24 ore:
25,689
Relative Volume:
0.13
Capitalizzazione di mercato:
$11.13M
Reddito:
-
Utile/perdita netta:
$-58.52M
Rapporto P/E:
-2.4833
EPS:
-2.09
Flusso di cassa netto:
$-45.03M
1 W Prestazione:
+7.68%
1M Prestazione:
+1,004%
6M Prestazione:
+504.90%
1 anno Prestazione:
+224.38%
Intervallo 1D:
Value
$4.75
$5.20
Intervallo di 1 settimana:
Value
$4.75
$5.37
Portata 52W:
Value
$0.224
$5.37

Nextcure Inc Stock (NXTC) Company Profile

Name
Nome
Nextcure Inc
Name
Telefono
240-399-4900
Name
Indirizzo
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Name
Dipendente
43
Name
Cinguettio
@nextcureinc
Name
Prossima data di guadagno
2025-03-07
Name
Ultimi documenti SEC
Name
NXTC's Discussions on Twitter

Confronta NXTC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NXTC
Nextcure Inc
5.19 11.13M 0 -58.52M -45.03M -2.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.36 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.92 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.73 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
570.25 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.76 29.19B 3.81B -644.79M -669.77M -6.24

Nextcure Inc Stock (NXTC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-11-04 Downgrade Ladenburg Thalmann Buy → Neutral
2022-03-01 Iniziato Ladenburg Thalmann Buy
2021-03-05 Aggiornamento Truist Hold → Buy
2021-01-15 Downgrade BofA Securities Neutral → Underperform
2020-07-16 Aggiornamento The Benchmark Company Hold → Buy
2020-07-13 Downgrade ROTH Capital Buy → Neutral
2020-07-13 Downgrade SunTrust Buy → Hold
2020-06-01 Downgrade BofA/Merrill Buy → Neutral
2020-06-01 Downgrade The Benchmark Company Buy → Hold
2020-05-26 Iniziato JMP Securities Mkt Outperform
2020-03-24 Iniziato The Benchmark Company Buy
2020-03-02 Iniziato ROTH Capital Buy
2020-01-13 Iniziato SunTrust Buy
2019-12-05 Iniziato Needham Buy
2019-11-26 Iniziato BTIG Research Buy
2019-07-09 Iniziato BofA/Merrill Buy
2019-06-03 Iniziato Morgan Stanley Overweight
2019-06-03 Iniziato Piper Jaffray Overweight
Mostra tutto

Nextcure Inc Borsa (NXTC) Ultime notizie

pulisher
10:54 AM

What analysts say about NextCure Inc. stockSuperior investment outcomes - Autocar Professional

10:54 AM
pulisher
07:27 AM

NextCure Inc. Stock Analysis and ForecastFree Predictions - Autocar Professional

07:27 AM
pulisher
Jul 22, 2025

What drives NextCure Inc. stock priceExceptional return forecasts - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Is NextCure Inc. a good long term investmentHigh-octane financial growth - Autocar Professional

Jul 21, 2025
pulisher
Jul 16, 2025

What makes NextCure Inc. stock price move sharplyConsistent Growth Alert - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Why NextCure Inc. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How NextCure Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Piper Sandler lowers NextCure stock price target to $15 after reverse split By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Piper Sandler lowers NextCure stock price target to $15 after reverse split - Investing.com India

Jul 15, 2025
pulisher
Jul 14, 2025

NextCure initiates one-for-twelve reverse stock split on Nasdaq By Investing.com - Investing.com Nigeria

Jul 14, 2025
pulisher
Jul 14, 2025

NextCure Implements Reverse Stock Split on Nasdaq - TipRanks

Jul 14, 2025
pulisher
Jul 14, 2025

NextCure initiates one-for-twelve reverse stock split on Nasdaq - Investing.com

Jul 14, 2025
pulisher
Jul 10, 2025

NextCure Announces One-for-Twelve Reverse Stock Split - TipRanks

Jul 10, 2025
pulisher
Jul 10, 2025

NextCure announces 1-for-12 reverse stock split effective July 14 - Investing.com Nigeria

Jul 10, 2025
pulisher
Jul 10, 2025

NextCure announces 1-for-12 reverse stock split effective July 14 By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 06, 2025

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX) - The Globe and Mail

Jul 06, 2025
pulisher
Jul 02, 2025

NextCure’s (NXTC) Buy Rating Reaffirmed at HC Wainwright - Defense World

Jul 02, 2025
pulisher
Jun 23, 2025

Eyes on Asia: AstraZeneca, NextCure, Sagimet Biosciences - BioXconomy

Jun 23, 2025
pulisher
Jun 17, 2025

Nextcure Inc: Analyzing NXTC Stock Trends - investchronicle.com

Jun 17, 2025
pulisher
Jun 17, 2025

Market Recap: Next Technology Holding Inc (NXTT)’s Positive Momentum, Closing at 1.40 - DWinneX

Jun 17, 2025
pulisher
Jun 17, 2025

Market Highlights: Nextcure Inc (NXTC) Ends on a Low Note at 0.50 - DWinneX

Jun 17, 2025
pulisher
Jun 17, 2025

NextCure tanks as it teams up with Simcere on novel ADC - The Pharma Letter

Jun 17, 2025
pulisher
Jun 17, 2025

NextCure and Simcere partner to develop SIM0505 for solid tumours - yahoo.com

Jun 17, 2025
pulisher
Jun 16, 2025

NextCure partners with Simcere Zaiming on cancer drug development By Investing.com - Investing.com South Africa

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure Joins China-ADC Gold Rush with $745M Simcere Deal - BioSpace

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure Inks $745M Deal With Simcere For Cancer Drug: Retail’s More Optimistic Despite Stock’s 27% Decline - Asianet Newsable

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure And Simcere Zaiming Partner To Develop CDH6-Targeting ADC SIM0505 For Solid Tumors - Nasdaq

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure signs up to $745 million deal with China's Simcere to develop cancer drug - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

Simcere Pharmaceutical's Unit Enters Into License Agreement With Nextcure - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure Enters Licensing Agreement with Simcere Zaiming - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure (NXTC) Partners with Simcere Zaiming for Innovative Cancer Treatment | NXTC Stock News - GuruFocus

Jun 16, 2025

Nextcure Inc Azioni (NXTC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$35.94
price down icon 0.47%
$102.36
price down icon 0.58%
$27.75
price up icon 4.47%
$113.94
price up icon 2.30%
biotechnology ONC
$295.76
price up icon 0.06%
Capitalizzazione:     |  Volume (24 ore):